Latest period
$3.23B
YoY change
-30.2%
5Y CAGR
-2.4%
Peak year (2023)
$5.00B
Latest annual
$3.33B
Total Equity history chart for Zoetis (ZTS) from 2010 to 2025
Latest: $3.33B
Total Equity growth chart for Zoetis (ZTS) from 2010 to 2025
Latest: -30.2%
Total Equity history table for Zoetis (ZTS) from 2010 to 2025
| 2025 | $3.33B | -30.2% | −$1.44B | ||
| 2024 | $4.77B | -4.5% | −$227.00M | ||
| 2023 | $5.00B | +13.4% | +$592.00M | ||
| 2022 | $4.41B | -3.0% | −$138.00M | ||
| 2021 | $4.54B | +20.5% | +$774.00M | ||
| 2020 | $3.77B | +39.2% | +$1.06B | ||
| 2019 | $2.71B | +23.9% | +$523.00M | ||
| 2018 | $2.19B | +23.4% | +$415.00M | ||
| 2017 | $1.77B | +19.0% | +$283.00M | ||
| 2016 | $1.49B | +39.2% | +$419.00M | ||
| 2015 | $1.07B | -18.5% | −$243.00M | ||
| 2014 | $1.31B | +39.5% | +$371.00M | ||
| 2013 | $940.00M | -76.7% | −$3.09B | ||
| 2012 | $4.03B | +8.2% | +$306.00M | ||
| 2011 | $3.72B | +11.2% | +$376.00M | ||
| 2010 | $3.34B | — | — |
- 2025$3.33B-30.2%
- 2024$4.77B-4.5%
- 2023$5.00B+13.4%
- 2022$4.41B-3.0%
- 2021$4.54B+20.5%
- 2020$3.77B+39.2%
- 2019$2.71B+23.9%
- 2018$2.19B+23.4%
- 2017$1.77B+19.0%
- 2016$1.49B+39.2%
- 2015$1.07B-18.5%
- 2014$1.31B+39.5%
- 2013$940.00M-76.7%
- 2012$4.03B+8.2%
- 2011$3.72B+11.2%
- 2010$3.34B—
Total Equity values are taken from Zoetis's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Equity at Zoetis (ZTS)
According to Zoetis's latest reported financial statements, the company's latest reported total equity is $3.23B. Net assets — also called stockholders' equity — equal total assets minus total liabilities. They represent the residual claim of shareholders on the company's assets and roughly track book value over time.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Zoetis (ZTS) total equity is $3.33B – plunged 30.2% year-over-year.
Zoetis total equity compound annual growth for the 2020–2025 (5 years) window is -2.4%, with a net decline across the window.
Zoetis total equity peaked at $5.00B in 2023; the latest annual figure is $3.33B in 2025 (33.3% below peak).
The record annual total equity stands at $5.00B, reached in 2023; the historical low of $940.00M was recorded in 2013.
Zoetis Total Equity by Year
Zoetis Total Equity 2025: $3.33B
In 2025, Zoetis reported total equity of $3.33B, plunged 30.2% below 2024.
Zoetis Total Equity 2024: $4.77B
Zoetis total equity in 2024 was $4.77B, edged down 4.5% below 2023.
Zoetis Total Equity 2023: $5.00B
2023's total equity for Zoetis came in at $5.00B, grew 13.4% from 2022. This figure represents the highest annual value in the available history.
Zoetis Total Equity 2022: $4.41B
Zoetis posted total equity of $4.41B in 2022, edged down 3.0% below 2021.
Zoetis Total Equity 2021: $4.54B
Zoetis total equity in 2021 was $4.54B.
See more financial history for Zoetis (ZTS).
Sector peers by Total Equity
Healthcare peers of Zoetis (ZTS), ranked by their latest total equity
| $94.11B | |
| $81.54B | |
| $52.61B | |
| $48.67B | |
| $30.52B | |
| $26.54B | |
| $8.66B | |
| −$3.27B |
- $94.11B
- $81.54B
- $52.61B
- $48.67B
- $30.52B
- $26.54B
- $8.66B
- −$3.27B
Frequently asked questions
Zoetis (ZTS) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation